While the CD8 + IC/CD4 + FOXP3 + IC ratio was higher in the pCR group, this difference did not reach statistical significance (20.7 ± 18.6 vs. 1.1 ± 1.0, p = 0.057).
← all excerpts
Spatial analysis of tumor immune microenvironment of TNBC with different neoadjuvant chemotherapy outcomes using multiplex Immunofluorescence.
2
0.0570
0.0710
The sentences
showed a trendp = 0.071
In patients with low TIL levels, the stromal CD8 + IC/CD4 + FOXP3 + IC ratio showed a trend toward being higher in the pCR group (5.9 ± 0.8 vs. 3.2 ± 1.9, p = 0.071).